Features and description of Clomid 50 mg Magnus Pharmaceuticals
Clomid is a drug containing clomiphene, a popular anti-estrogen. Clomid 50 mg Magnus Pharmaceuticals is needed apart from a treatment with anabolic steroids prone to aromatization. Without it, the athlete has excess estrogen and side effects develop.
How Clomid 50 mg Magnus Pharmaceuticals affects the body
Anti-estrogens in a man’s body work in the following way:
- It stimulates the production of gonadoliberin.
- Increase the production of LH and FSH in the pituitary gland.
- Improve testosterone synthesis in the testes.
Clomid 50 mg Magnus Pharmaceuticals does this by acting on the estrogen receptors found in the pituitary gland. Clomid binds to them, so estrogen cannot bind to them. As a result, their amount in the blood does not change, yet they no longer cause side effects.
The drug restores the activity of the pituitary gland, prevents testicular atrophy and excess estrogen, which manifests itself in gynecomastia, edema and other problems.
Negative consequences
When taking anti-oestrogens, the level of insulin-like growth factor decreases. And this substance is very important for gaining muscle mass and developing physical indicators. In addition, the drug reduces the effectiveness of steroids taken in parallel.
In rare cases, vision problems may occur. For some people Clomid is not effective in restoring testicular function.
Characteristics of use
Clomid 50 mg Magnus Pharmaceuticals is connected in the last week of the course. This allows you to achieve the result of the steroid and protect the athlete from the appearance of side effects. The tool is used only with flavored steroids. For example, testosterone and its derivatives.
Clomid as part of post-cycle therapy is taken another 2-3 weeks after the end of steroid treatment. To find out exactly when PCT can be completed, a blood test for hormones is performed.
Be sure to consult your doctor. Get tested and rule out contraindications before taking Clomid.
List of references
- “Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome” by Richard S. Legro, et al. (New England Journal of Medicine, 2007)
- “Clomiphene citrate and enclomiphene for the treatment of hypogonadal androgen deficiency” by Matthew B. Comite, et al. (Expert Opinion on Investigational Drugs, 2013)
- “Clomiphene citrate – end of an era? A mini-review” by Fahimeh Ramezani Tehrani, et al. (Gynecological Endocrinology, 2021)
- “Clomiphene citrate effect on testosterone level and semen parameters in men with unexplained infertility” by Ashraf Alleyassin, et al. (Urology Journal, 2009)
- “Comparison of tamoxifen and clomiphene citrate for ovulation induction: a meta-analysis” by Alaa S. Al-Inany, et al. (Human Reproduction Update, 2005)
Reviews
Clear filtersThere are no reviews yet.